3-n-methylspiperone has been researched along with Parkinsonian Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imafuku, I; Iso-o, N; Kanazawa, I; Kwak, S; Momose, T; Shirouzu, I; Yamamoto, T; Yoshimura, M | 1 |
1 other study(ies) available for 3-n-methylspiperone and Parkinsonian Disorders
| Article | Year |
|---|---|
Hemiparkinsonism associated with a mesencephalic tumor.
Topics: Brain Stem Neoplasms; Carbon Radioisotopes; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Functional Laterality; Humans; Middle Aged; Parkinsonian Disorders; Putamen; Spiperone; Tomography, Emission-Computed | 2002 |